Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

celecoxib-loaded porous oxidized silicon microparticles

Based on

1 Articles
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

p-doped silicon

Type Complex Compound
Formula
Role raw materials
2

atomic oxygen

oxygen atom
Type Single Compound
Formula O
Role layer
3

4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide

celecoxib celebrex CEB CLX
Type Complex Compound
Formula
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug release dependent on pH

4 more entries available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Method Source
differential scanning calorimetry

1 more entry available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
Caco-2/HT-29-MTX cells co-culture monolayer

1 more entry available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  1. NJ3tW6TTDygW3ybUPa
Product

celecoxib-loaded porous oxidized silicon microparticles

Method 2

Type: Physical formation
Source:
Starting materials
  1. mefyOoU6drtrV9ytX6
Product

celecoxib-loaded porous oxidized silicon microparticles

Method 3

Type: Physical formation
Source:
Starting materials
  1. b39xHDnKNwVPwutsP9
Product

celecoxib-loaded porous oxidized silicon microparticles

Method 4

Type: Physical formation
Source:
Starting materials
  1. G1Q71NKXCsRi2o4tsv
Product

celecoxib-loaded porous oxidized silicon microparticles

Method 5

Type: Physical formation
Source:
Starting materials
  1. 1P7Lsml7jCKGWpBj05
Product

celecoxib-loaded porous oxidized silicon microparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial